Mudit K. Jain, PhD

Mudit K. Jain, PhD
Founder and General Partner



Mudit is a Founding General Partner of Strategic Healthcare Investment Partners (S.H.I.P.), and the CEO and co-founder of NuXcel, a medical device accelerator. Mudit also co-founded and serves as Chairman of the Board of ShiraTronics, Inc., a NuXcel spin off company.

Mudit brings over two decades of medical device industry experience across company formation, R&D, business development, and venture capital, with a global perspective on healthcare based on his experiences in USA, Ireland, and India. Mudit has served on the boards of several medical device companies, from early to commercial growth stage, resulting in successful IPOs and M&A transactions.

Most recently, as a General Partner with Synergy Life Science Partners, Mudit delivered top quartile performance. In addition to his private venture capital experiences at S.H.I.P, and Synergy Life Science Partners, Mudit also brings a strategic investment perspective based on his tenure at Johnson and Johnson Development Corporation.

Prior to his investing career, Mudit held operational roles in the Cardiac Rhythm Management Division of Guidant Corporation, and played a key role in developing novel device technologies for heart failure, remote monitoring, and cardiac ablation. Mudit also played an important role in product development for start-ups like Epicor, Inc. (acquired: St. Jude Medical), and Cardiac Pathways Corporation (acquired: Boston Scientific). Mudit holds eight issued patents and has authored several peer reviewed publications.

Mudit also serves on the Board of Visitors of the Graduate School at Duke University, External Advisory Board of John Hopkins University Center for Bioengineering Innovation and Design, and on the Board of One Heart Health, a healthcare focused non-profit focused on providing access to pediatric populations in underprivileged geographies.

Mudit graduated with a B.E. in Electrical Engineering from REC, Nagpur, India, where he was a gold medal recipient for academic achievements. He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.


REPRESENTATIVE COMPANIES

Inspire
iRhythm
Aptus Endosystems
ShiraTronics
NuXcel
CVR
NeoChord
Noctrix Health
cardiomems
Impres

SAN FRANCISCO   |   IRELAND


SAN FRANCISCO   |   IRELAND


Copyright 2020 Strategic Healthcare Investment Partners. All rights reserved.